Study guide
Varices, ulcers, reflux and lower GI bleeding
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Varices, ulcers, reflux and lower GI bleeding
Key Takeaways Explain This Topic AI
Suspected variceal bleeding requires vasoactive therapy, antibiotics and urgent endoscopic care.
Confirm H. pylori eradication after the appropriate antibiotic and PPI washout.
Dysphagia, bleeding or weight loss requires investigation rather than repeated empirical reflux treatment.
Last updated: October 2026
Variceal vs Non-Variceal Upper GI Bleeding
Rapid clinical discrimination between non-variceal and variceal haemorrhage dictates initial pharmacotherapy and endoscopic strategy.
Non-Variceal Bleeding (Peptic Ulcers, Tears, Ectasias)
Aetiology: Peptic ulcer disease ( 50 % 50\% 50% ), gastroduodenal erosions ( 15 % 15\% 15% ), Mallory-Weiss tears ( 10 % 10\% 10% , mucosal laceration at the gastro-oesophageal junction post-retching), Dieulafoy lesions (aberrant submucosal calibre-persistent artery), and upper GI malignancy ( 5 % 5\% 5% ).
Pharmacotherapy: Initiate high-dose intravenous proton pump inhibitor (PPI) therapy upon admission (e.g. pantoprazole 80 mg IV bolus followed by an 8 mg/hour continuous infusion for 72 hours , or 40 mg 40\text{ mg} 40 mg IV twice daily). Maintaining intragastric p H > 6 pH > 6 p H > 6 promotes platelet aggregation and prevents pepsin-mediated clot lysis.
Endoscopy Timing: Perform upper endoscopy within 24 hours of presentation (within 12 hours if haemodynamically unstable despite fluid resuscitation).
Endoscopic Haemostasis: Guided by the Forrest Classification :
Forrest Ia (Spurting arterial) and Ib (Oozing) : High rebleeding risk ( 55 − 90 % 55-90\% 55 − 90% ). Mandates dual endoscopic therapy: injection of dilute adrenaline ( 1 : 10 , 000 1:10,000 1 : 10 , 000 ) combined with a second mechanical or thermal modality (through-the-scope clips or bipolar electrocoagulation).
Forrest IIa (Non-bleeding visible vessel) and IIb (Adherent clot) : Moderate to high risk ( 25 − 50 % 25-50\% 25 − 50% ). Mandates endoscopic intervention (clot removal and dual therapy).
Forrest IIc (Flat pigmented spot) and III (Clean ulcer base) : Low rebleeding risk ( < 5 % < 5\% < 5% ). No endoscopic intervention required; switch to oral PPI.
Variceal Bleeding (Portal Hypertension)
Aetiology: Rupture of dilated submucosal gastro-oesophageal varices driven by elevated portal venous pressure gradient ( H V P G ≥ 12 mmHg HVPG \ge 12\text{ mmHg} H V PG ≥ 12 mmHg ) in patients with cirrhosis.
Immediate Vasoactive Pharmacotherapy: Must be administered immediately upon suspicion of variceal bleeding, prior to endoscopy:
Terlipressin: Synthetic vasopressin analogue with selective V 1 V_1 V 1 receptor agonism causing splanchnic arterial vasoconstriction and rapid reduction in portal inflow. Dose: 2 mg IV stat bolus, then 1-2 mg IV every 4-6 hours for up to 2-5 days.
Octreotide: Synthetic somatostatin analogue; alternatives when terlipressin is unavailable or contraindicated (e.g. severe peripheral vascular disease). Dose: 50 μ g 50\ \mu\text{g} 50 μ g IV bolus followed by 50 μ g/hour 50\ \mu\text{g/hour} 50 μ g/hour infusion.
Antibiotic Prophylaxis: Mandatory in all cirrhotic patients presenting with upper GI bleeding regardless of ascites. Administer intravenous ceftriaxone 1 g daily for 5 to 7 days . Antibiotic prophylaxis reduces bacterial translocation, prevents spontaneous bacterial peritonitis (SBP), decreases rebleeding, and confers a proven survival advantage.
Endoscopic Haemostasis: Perform urgent gastroscopy within 12 hours of presentation. The gold standard is Endoscopic Variceal Ligation (EVL / band ligation) for oesophageal varices. Gastric fundal varices are treated with endoscopic cyanoacrylate tissue adhesive glue.
Rescue Interventions: If endoscopic haemostasis fails or exsanguinating haemorrhage precludes visualization:
Balloon Tamponade: Placement of a Sengstaken-Blakemore or Minnesota tube provides mechanical compression of bleeding varices. Used strictly as a temporary bridge ( < 24 hours < 24\text{ hours} < 24 hours ) due to risks of oesophageal necrosis and aspiration.
TIPSS: Early Transjugular Intrahepatic Portosystemic Shunt (TIPSS) within 72 hours is indicated for high-risk patients (Child-Pugh C < 14 < 14 < 14 or Child-Pugh B with active bleeding at endoscopy) to decompress the portal circulation.
Peptic Ulcer Disease (PUD) & Helicobacter pylori
Peptic ulceration results from an imbalance between protective mucosal defense factors (mucus, bicarbonate, prostaglandins, blood flow) and aggressive luminal factors (hydrochloric acid, pepsin).
Major Aetiological Drivers
Helicobacter pylori Infection: Microaerophilic, Gram-negative flagellated bacillus residing in the gastric mucous layer. Responsible for > 85 % > 85\% > 85% of duodenal ulcers and > 65 % > 65\% > 65% of gastric ulcers. Urease production hydrolyses urea to ammonia, buffering gastric acid and damaging the surrounding epithelium.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) & Aspirin: Non-selective NSAIDs inhibit cyclooxygenase-1 (COX-1), blocking cytoprotective prostaglandin E 2 E_2 E 2 and I 2 I_2 I 2 synthesis, impairing mucosal microcirculation and bicarbonate secretion.
Uncommon Causes: Zollinger-Ellison syndrome (gastrinoma with severe hyperchlorhydria), severe physiological stress (Curling ulcers in major burns; Cushing ulcers in intracranial pathology).
Diagnostic Investigations for H. pylori
Urea Breath Test (UBT) (Carbon-13 or Carbon-14): Sensitivity / Specificity: > 95 % / > 95 % > 95\% / > 95\% > 95%/ > 95% ; Clinical Utility & Diagnostic Caveats: Non-invasive test of choice to confirm active infection and verify eradication. False negatives occur if patient has taken a PPI within 2 weeks or antibiotics / bismuth within 4 weeks .
Faecal Antigen Test (SAT) : Sensitivity / Specificity: > 95 % / > 95 % > 95\% / > 95\% > 95%/ > 95% ; Clinical Utility & Diagnostic Caveats: Excellent alternative non-invasive test detecting active bacterial shed. Same 2-week PPI and 4-week antibiotic cessation requirements as UBT.
Endoscopic Biopsy & Rapid Urease Test (CLO test) : Sensitivity / Specificity: > 90 % / > 95 % > 90\% / > 95\% > 90%/ > 95% ; Clinical Utility & Diagnostic Caveats: Performed during gastroscopy; biopsy tissue placed into urea-containing agar with phenol red indicator. Subject to false negatives from recent PPI use.
Histopathology & Culture : Sensitivity / Specificity: > 95 % / > 98 % > 95\% / > 98\% > 95%/ > 98% ; Clinical Utility & Diagnostic Caveats: Direct microscopic visualization with Giemsa or silver stains. Allows antimicrobial susceptibility profiling in refractory cases.
Serology (Serum IgG) : Sensitivity / Specificity: 80 − 90 % / 70 − 80 % 80-90\% / 70-80\% 80 − 90%/70 − 80% ; Clinical Utility & Diagnostic Caveats: Cannot differentiate past resolved infection from active infection. Unreliable for confirming eradication; rarely indicated in modern practice.
AMC Clinical Rule: Gastric ulcers carry a 3 − 5 % 3-5\% 3 − 5% risk of underlying gastric adenocarcinoma. Unlike duodenal ulcers, all gastric ulcers require multiple edge and base biopsies during endoscopy, followed by a repeat surveillance gastroscopy in 6 to 8 weeks to confirm complete mucosal healing.
Eradication Regimens per Australian Therapeutic Guidelines (eTG)
First-Line Triple Therapy (7 to 14 days):
Standard-dose PPI twice daily (e.g. esomeprazole 20 mg 20\text{ mg} 20 mg bd, or omeprazole 20 mg 20\text{ mg} 20 mg bd)
- Amoxicillin 1000 mg orally twice daily
- Clarithromycin 500 mg orally twice daily
Penicillin Hypersensitivity: Substitute amoxicillin with metronidazole 400 mg orally twice daily.
Second-Line / High-Resistance Bismuth Quadruple Therapy (10 to 14 days):
- Standard-dose PPI twice daily
- Bismuth subcitrate (or subsalicylate) standard dose
- Metronidazole 400 mg orally three times daily
- Tetracycline 500 mg orally four times daily
Confirmation of Eradication: Mandatory for all patients treated for PUD. Repeat Urea Breath Test or Faecal Antigen Test at least 4 weeks after completing antibiotics and at least 2 weeks after stopping PPI therapy .
Reflux and indigestion
Heartburn and acid regurgitation can support gastro-oesophageal reflux, with assessment of meals, posture, medicines and weight-related factors. Appropriate lifestyle measures and a time-limited acid-suppression trial can help a low-risk typical presentation, followed by review and the lowest effective regimen. Dysphagia, odynophagia, bleeding, anaemia, involuntary weight loss or persistent atypical symptoms require investigation rather than repeated empirical prescriptions. Chest pain must also be assessed for cardiac causes; response to antacid does not exclude ACS. Dyspepsia can reflect functional disease, ulcer or malignancy. Select H. pylori testing with attention to PPI/antibiotic effects, and arrange endoscopy according to risk and alarm features. Refractory symptoms need diagnostic review, not automatic lifelong dose escalation.
Lower Gastrointestinal Bleeding (LGIB)
Lower GI bleeding accounts for approximately 20 − 30 % 20-30\% 20 − 30% of all major GI bleeding presentations. Over 80 % 80\% 80% of acute LGIB cases resolve spontaneously with supportive measures.
Aetiologies
Diverticular Bleeding ( 30 − 40 % 30-40\% 30 − 40% ): The single most common cause of major acute lower GI bleeding. Arises from rupture of the nutrient arteriole (vasa recta) traversing the dome or neck of a colonic diverticulum. Characteristically presents as sudden, painless, massive haematochezia. True diverticulitis is typically absent during a bleed.
Angiodysplasia / Vascular Ectasias ( 10 − 15 % 10-15\% 10 − 15% ): Acquired, tortuous, thin-walled submucosal arteriovenous malformations predominantly located in the caecum and ascending colon of elderly patients ( > 65 years > 65\text{ years} > 65 years ). Associated with aortic stenosis ( Heyde syndrome , where shear stress degrades von Willebrand factor multimers) and end-stage renal failure.
Colitis ( 15 − 20 % 15-20\% 15 − 20% ):
Ischaemic Colitis: Sudden crampy left iliac fossa pain followed by bloody diarrhoea, characteristically occurring at mesenteric 'watershed' regions (Griffiths' point at the splenic flexure, Sudeck's point at the rectosigmoid junction) following transient systemic hypoperfusion.
Infectious Colitis: Campylobacter, Salmonella, Shigella, E. coli O157:H7, Clostridioides difficile.
Inflammatory Bowel Disease: Ulcerative colitis, Crohn's disease.
Haemorrhoids and Anal Fissures ( 10 − 15 % 10-15\% 10 − 15% ): Fresh, bright red blood coating the surface of formed stool or dripping into the toilet bowl; rarely causes haemodynamic compromise.
Neoplasia ( 10 % 10\% 10% ): Colorectal adenocarcinoma or large polyps; typically presents with occult bleeding, chronic microcytic iron deficiency anaemia, or intermittent altered blood.
Diagnostic & Management Pathway for Acute LGIB
Localisation: History, examination, haemodynamics and the clinical pattern guide endoscopy or imaging. Nasogastric aspiration is not mandatory and a negative aspirate does not exclude upper-GI bleeding. Unstable haematochezia can be brisk upper-GI bleeding; CT angiography can also help localise active lower bleeding.
Haemodynamically Unstable Patient: If active, brisk haematochezia persists with shock despite aggressive fluid resuscitation:
Investigation of Choice: Urgent contrast-enhanced Computed Tomography Mesenteric Angiography (CTMA) . CTMA can detect active arterial bleeding at extravasation rates as low as 0.3 − 0.5 mL/min 0.3-0.5\text{ mL/min} 0.3 − 0.5 mL/min with high anatomical accuracy.
Definitive Treatment: If CTMA identifies active contrast extravasation, transfer the patient directly to the interventional radiology suite for transcatheter arterial embolisation (TAE) . Emergency segmental colectomy is reserved for failed embolisation or uncontrollable exsanguination.
Haemodynamically Stable Patient:
Admit to an inpatient ward, optimize haemoglobin, and correct coagulopathies.
Perform colonoscopy following rapid oral bowel lavage (e.g. 4 litres of polyethylene glycol solution). Colonoscopy permits mucosal visualization, tissue biopsy, and direct endoscopic haemostasis (haemostatic clips, thermal probe, or argon plasma coagulation for angiodysplasia).
Primary references (checked 7 October 2026): National Blood Authority PCC transition .